Benitec Biopharma Limited

Developer of RNAi-based therapies for infectious, ocular, and genetic diseases

placeSydney, New South Wales, Australia calendar_todayFounded 1997 groups18 employees language benitec.com

Registered entities

Innovation

17 patent families (11 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 647 times.

YearFilings
20132
20143
20154
20164
20176
20188
20198
20207
20215
20224
20233
20251

Social engagement

Social engagement: 2.1K social following, 8 posts in the last 12 months — above the industry median.

Recent activity

11 May 2026
Event
OculopharyngealMuscular Dystrophy educational webinar
6 May 2026
Event
2026 American Society of Gene & Cell Therapy Annual Meeting
17 Apr 2026
Product launch
DNA-directed RNAi (#ddRNAi) platform
Coming soon